Upregulation of natural killer cells functions underlies the efficacy of intratumorally injected dendritic cells engineered to produce interleukin-12
- 1 March 2002
- journal article
- Published by Elsevier in Experimental Hematology
- Vol. 30 (3), 195-204
- https://doi.org/10.1016/s0301-472x(01)00792-5
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Feeding dendritic cells with tumor antigens: self-service buffet or à la carte?Gene Therapy, 2000
- Dendritic Cells in Cancer ImmunotherapyAnnual Review of Immunology, 2000
- Intratumoral Administration of Adenoviral Interleukin 7 Gene-Modified Dendritic Cells Augments Specific Antitumor Immunity and Achieves Tumor EradicationHuman Gene Therapy, 2000
- Regression of colon cancer and induction of antitumor immunity by intratumoral injection of adenovirus expressing interleukin-12Cancer Gene Therapy, 1999
- IL-12 Acts Directly on DC to Promote Nuclear Localization of NF-κB and Primes DC for IL-12 ProductionImmunity, 1998
- A Mechanism for the Specific Immunogenicity of Heat Shock Protein-Chaperoned PeptidesScience, 1995
- Fibroblasts as Efficient Antigen-Presenting Cells in Lymphoid OrgansScience, 1995
- Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha.The Journal of Experimental Medicine, 1994
- Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor.The Journal of Experimental Medicine, 1992
- Severe Herpesvirus Infections in an Adolescent without Natural Killer CellsNew England Journal of Medicine, 1989